The Modern Urologist

In this episode, Dr. Paul Sieber and Ashley Rentisky, PA-C, are joined by Dr. Evan Goldfischer, past president of LUGPA, to address the underutilization of germline and tumor (somatic) testing somatic testing in prostate cancer management. They will discuss challenges practices face in integrating genetic testing into clinical workflows and offer strategies for overcoming barriers.  Tune in for ex...

Dr. Paul Sieber and co-host Ashleigh Renitsky, Oncology PA, are joined by Dr. Morris from Urology Associates of Nashville to discuss how clinical guidelines have driven increased awareness of germline and somatic mutations in prostate cancer. They discuss how germline and somatic testing can help personalize treatment strategies and share real world case studies. The conversation also encourages t...

In the second episode of our miniseries, Precision Oncology and Prostate Cancer: The New Standard of Care , Dr. Paul Sieber and Ashleigh Renitsky, Oncology PA, will break down the different types of genetic and molecular tests—including gene expression, germline, somatic, and circulating tumor DNA tests—discuss which patients qualify for each, and explore how to implement streamlined testing proto...

The Modern Urologist Podcast has launched a new miniseries, Precision Oncology and Prostate Cancer: The New Standard of Care, hosted by Dr. Paul Sieber and Ashleigh Renitsky, Oncology PA. This series will focus on the evolving role of genetic testing in prostate cancer care and its impact on personalized patient treatment plans. Episode #1 - Genetic testing basics The first installment will provid...

In this conversation, Dr. Tim Richardson from Wichita Urology and Dr. Ben Lowentritt from Chesapeake Urology discuss the integration and utilization of Advanced Practice Providers (APPs) in urology practices, particularly within advanced prostate cancer (APC) clinics. Dr. Lowentritt explains the benefits of using APPs to address physician shortages, increase efficiency, and more.  Send a text

Dr. Tim Richardson from Wichita Urology and Dr. Jonathan Henderson from Arkansas Urology discuss the use and benefits of Prolaris testing in prostate cancer management. Dr. Henderson elaborates on how Prolaris aids in decision-making for his prostate cancer patients, highlighting its role in reducing overtreatment and undertreatment.  Send a text

Dr. Tim Richardson from Wichita Urology interviews Dr. Scott Sellinger, the current president - elect of the Large Urology Group Practice Association (LUGPA). They discuss LUGPA's history, current status, and future goals. Initially founded to support large independent urology practices, LUGPA now includes any independent urology practice. Dr. Sellinger also highlights the challenges facing i...

In this episode of The Modern Urologist, Dr. Mark Edney is joined by Dr. Paul Sieber, a urologist from Lancaster, Pennsylvania, to discuss the use of genetic testing in the diagnosis and treatment of prostate cancer. Dr. Sieber emphasizes the importance of hereditary cancer testing, as well as tissue-based biomarkers like Prolaris®, in determining the best treatment plans for this prostate cancer...

On this episode of TMU we're diving deep into the rapidly evolving landscape of prostate cancer diagnosis and treatment with special guest, Dr. Adam Cole, a board-certified pathologist. Dr. Cole will discuss the traditional Gleason grading system, the limitations of pathology, and how incorporating genetic markers can improve patient outcomes.   Send a text

In this episode of TMU we have the pleasure of being joined by two urology experts, Dr. Ravi Rajan, Urologist, and Dr. William Ding, Radiation Oncologist, as they discuss topics ranging from genetic testing in prostate cancer for personalized treatment plans to the importance of collaboration between urologists and radiation oncologists. Our guests highlight the significance of effective communica...

Join our panel of experts, Dr. Neal Shore, Dr. Ben Lowentritt, Dr. Ted Schaefer, and Dr. Jonathan Tward, as they discuss the various components and utility of a full workup for localized prostate cancer. They explore the importance of germline testing and how it has significant implications for personalized treatment choices. They will also discuss and examine the use of traditional biomarkers lik...

On this episode of TMU, Dr. Mark Edney welcomes Dr. Deepak Kapoor as they dive into the world of private equity and healthcare policy. They discuss the opportunities and challenges faced by private practices in the field of Urology, and explore the topic of private equity with Dr. Kapoor's experiences as the chairman of Solaris Health. Listeners will gain insight into the differences between...

 On this episode of TMU, we sit down with Ray Wezik, the Director of Policy and Advocacy for the American Urological Association (AUA), as we dive into the world of patient advocacy and lobbying. Ray shares his perspective as someone who works with over 75 patient advocacy organizations to leverage their voices and become better advocates together. We discuss the importance of collaboration betwee...

On this episode of TMU, we’re joined by Nilay Gandhi, Urologist at Potomac Urology in Northern Virginia, as he shares his personal story on why he chose to pursue urology and his involvement in patient advocacy. Dr. Gandhi also discusses how incorporating genetic testing into his practice has improved patient care. Lastly, we’ll cover the growing presence of advanced practice providers in urology...

Dr. TJ Slavin, Chief Medical Officer of Myriad Genetics hosts this episode of the Modern Urologist joined by Dr. Angelo Baccala, at Lehigh Valley Health Network and Kara Cossis, PA-C, MPH, at Chesapeake Urology, to discuss genetic testing advancements in prostate cancer care to improve patient outcomes. Panelists' will dive into the rising rates of prostate cancer due to advanced diagnosis an...

In this episode of The Modern Urologist, we are joined by Dr. David Levy who has done extensive research on prostate cancer nutrition and treatment. Dr. Levy will discuss measures that can be taken to decrease risk of disease such as taking supplements and vitamins. In addition, he mentions which foods to incorporate in your diet and those to avoid to possibly prevent or delay prostate cancer prog...

In this episode, we continue our conversation with Shelby Moneer and Ali Manson with ZERO – The End of Prostate Cancer, as they discuss the education and research support ZERO provides. They will also talk through where they see the organization going.   Send a text

In the first of a two-part series, Shelby Moneer, VP of Patient Programs and Education and Ali Manson, VP of Government Relations at ZERO – The End of Prostate Cancer, join Dr. Todd Cohen to discuss their advocacy efforts to educate and support all men who are impacted by prostate cancer. They will discuss ZERO's health equity work to combat racial disparity, creating support groups for patie...

In this episode Dr. Todd Cohen is joined by Geoff McLennan, a board member of Active Surveillance Patients International (ASPI), an advocacy group created by men with prostate cancer for men with prostate cancer. When Geoff was diagnosed with localized prostate cancer he was shocked to hear he could actively watch his cancer and not undergo extensive treatment. Geoff has now been on Active Surveil...

In this episode, two guests from Urology Austin, Jessica Stewart, VP of Business Development, and Marco Carlos, Clinical Care Director, join Dr. Cohen to discuss their elevated nurse navigation program and how they care for their prostate cancer patients. They will talk through the implementation of clinical care pathways across the entire prostate cancer spectrum, and dive into the navigator cert...

Dr. Marc Greenstein, from Advanced Urology, joins Dr. Todd Cohen to discuss his various roles as a urologist in the community and how he decided to get into the field of Urology. Dr. Greenstein provides insight to how his practice has adapted to the COVID-19 pandemic and dives into where he sees the future of Urology going.  Send a text

In this episode, Radiation Oncologist, Jeffery Skinner from Chesapeake Urology sits down with Dr. Todd Cohen to discuss how a radiation oncologist determines the proper treatment for a prostate cancer patient. Dr. Skinner will also share his thoughts on androgen deprivation therapy (ADT) in conjunction with radiation treatment. Send a text

In this installment of The Modern Urologist, Dr. Todd Cohen was able to sit down with Neal Dunn, a former urologist and current Congressman of Florida’s 2nd Congressional District. They will discuss his transition from a practicing urologist to a politician, along with the biggest battles and successes he has faced in this role thus far. Congressman Dunn will also talk through his involvement with...

Dr. Howard Soule, Chief Scientific Officer of the Prostate Cancer Foundation, joins Dr. Todd Cohen on this episode of The Modern Urologist to discuss his involvement with the Prostate Cancer Foundation. He will also talk through the history of the foundation and where he sees them going in the future. In addition, Dr. Soule gives insight to how the foundation has raised awareness for patient commu...

In this episode, Dr. Laurence Klotz, Professor of Surgery at the University of Toronto, sits down with Dr. Todd Cohen to discuss his role in the advancement of Active Surveille in Urology. He dives into how himself and two colleagues came up with a strategy to reduce over treatment in prostate cancer patients. Dr. Klotz will also talk about the early controversy surrounding Active Surveillance and...